首页> 外文期刊>The pharmaceutical journal >Diabetes gene identification could lead to new therapy
【24h】

Diabetes gene identification could lead to new therapy

机译:糖尿病基因鉴定可能导致新疗法

获取原文
获取原文并翻译 | 示例
           

摘要

A gene that appears to play a critical role in the development of type 1 diabetes has been identified by researchers at the North Shore-Long Island Health System in Manhasset,New York.The gene is responsible for making an immune system messenger called macro-phage migration inhibitory factor(MIF),a protein involved in the regulation of the immune system.Last year,the researchers showed that ISO-1,a synthetic compound developed by them,prevented the onset of diabetes by inhibiting MIF(PJ,10 April 2004,p441).
机译:纽约Manhasset的North Shore-Long Island Health System的研究人员已经鉴定出一种在1型糖尿病的发展中起关键作用的基因,该基因负责制造一种称为巨噬细胞的免疫系统信使。迁移抑制因子(MIF)是一种调节免疫系统的蛋白质。去年,研究人员表明,由他们开发的合成化合物ISO-1通过抑制MIF来预防糖尿病的发作(PJ,2004年4月10日,p441)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号